Matricelf (TASE: MTLF) Enters Strategic Collaboration with Sheba Medical Center to Advance First in Human Clinical Program in Spinal Cord Injury
PR Newswire —
TEL AVIV, Israel, March 24, 2026 /PRNewswire/ -- Matricelf Ltd. (TASE: MTLF), a regenerative medicine company developing autologous engineered neural tissue therapies, today announced a strategic collaboration with Sheba Medical Center, Tel Hashomer, ranked 7th globally by Newsweek, to...